Physician profile
Magendra Thakur
NPI 1427074343
$60,643.00
in general payments reported to CMS, 2019-2025
21 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,233 · 2020: $9,379 · 2021: $12K · 2022: $16K · 2023: $20K · 2024: $482 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $1,696 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,500.00 |
| Food and Beverage | $1,695.82 |
| Education | $140.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $57,129.81 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $985.92 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.54 | 2019-2025 | Ofev |
| Novo Nordisk INC | $431.31 | 2019-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $375.43 | 2019-2022 | |
| Genzyme Corporation | $326.15 | 2021-2025 | |
| Harmony Biosciences LLC | $142.49 | 2020 | |
| Philips North America LLC | $122.24 | 2019-2020 | |
| Lilly USA, LLC | $105.04 | 2019-2025 | Zepbound |
| Jazz Pharmaceuticals INC. | $102.46 | 2019-2024 | |
| Pulmonx Corporation | $83.44 | 2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Csl Behring | $67.80 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $56.86 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $32.17 | 2019 | |
| Genentech USA, INC. | $19.92 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $19.16 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.68 | 2019 | |
| Insmed, INC. | $16.24 | 2023 | Arikayce |
| Mallinckrodt Enterprises LLC | $15.40 | 2019 | |
| Circassia INC. | $14.67 | 2019 | |
| Amarin Pharma, INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Magendra Thakur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.